PHADECODE XA INHIBITOR ASSAY— 510(k) K792019

Name: FDA 510(k) clearance K792019
Creator: U.S. Food and Drug Administration
Published: 1979-11-05

Substantially Equivalent

Pharmaseal Div., Baxter Healthcare Corp.

FDA 510(k) clearance K792019 for PHADECODE XA INHIBITOR ASSAY, Substantially Equivalent on 1979-11-05. Applicant: Pharmaseal Div., Baxter Healthcare Corp.. Device class: 2.

Clearance details

Applicant: Pharmaseal Div., Baxter Healthcare Corp.
Product code: Code JBQ
Device class: Class 2
Regulation: 21 CFR 864.7060
Advisory panel: Hematology
Date received: 1979-10-09
Decision date: 1979-11-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JBQ

view all

K242952 — INNOVANCE Antithrombin2025-03-28
K081769 — INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO52009-05-28
K070301 — HEMOSIL ANTITHROMBIN2007-02-23
K062431 — HEMOSIL LIQUID ANTITHROMBIN2006-09-01
K043007 — BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 2211052005-11-07

More clearances from Pharmaseal Div., Baxter Healthcare Corp.

view all

K792369 — HYPERALIMENTATION DRESSING TRAY1979-12-10
K792141 — CONTINUOUS FLUSH DEVICE1979-12-05
K791773 — VENTILATOR TUBE WITH FILTER1979-10-22
K791156 — AMIPAQUE MYELOGRAM TRAY1979-07-30
K790896 — TWO-WAY ANESTHESIA FILTER1979-06-05

Data sourced from openFDA. This site is unofficial and independent of the FDA.